State Street Corp Trims Position in Viemed Healthcare, Inc. (NASDAQ:VMD)

State Street Corp trimmed its position in Viemed Healthcare, Inc. (NASDAQ:VMD) by 5.1% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 604,796 shares of the company’s stock after selling 32,378 shares during the period. State Street Corp owned about 1.55% of Viemed Healthcare worth $4,433,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in the company. Perkins Coie Trust Co purchased a new position in Viemed Healthcare during the third quarter valued at $73,000. Evernest Financial Advisors LLC bought a new position in shares of Viemed Healthcare in the second quarter worth about $66,000. PDT Partners LLC purchased a new position in shares of Viemed Healthcare during the 3rd quarter valued at about $78,000. Walleye Capital LLC bought a new position in shares of Viemed Healthcare during the 3rd quarter valued at approximately $87,000. Finally, SG Americas Securities LLC purchased a new stake in Viemed Healthcare in the 3rd quarter worth approximately $89,000. 74.24% of the stock is currently owned by institutional investors.

Viemed Healthcare Price Performance

NASDAQ VMD opened at $8.16 on Monday. The stock has a market cap of $317.73 million, a price-to-earnings ratio of 30.22 and a beta of 1.46. Viemed Healthcare, Inc. has a 12 month low of $6.21 and a 12 month high of $10.44. The company’s 50 day moving average is $8.72 and its two-hundred day moving average is $7.79. The company has a current ratio of 1.31, a quick ratio of 1.19 and a debt-to-equity ratio of 0.03.

Viemed Healthcare (NASDAQ:VMD) last announced its quarterly earnings data on Wednesday, November 6th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of $0.08 by $0.02. Viemed Healthcare had a net margin of 4.87% and a return on equity of 8.72%. The firm had revenue of $58.00 million for the quarter.

Insider Transactions at Viemed Healthcare

In other Viemed Healthcare news, Director Randy E. Dobbs sold 36,261 shares of Viemed Healthcare stock in a transaction on Wednesday, November 13th. The shares were sold at an average price of $9.28, for a total value of $336,502.08. Following the sale, the director now directly owns 107,706 shares in the company, valued at approximately $999,511.68. The trade was a 25.19 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Nitin Kaushal sold 30,000 shares of the stock in a transaction dated Monday, November 11th. The shares were sold at an average price of $9.56, for a total transaction of $286,800.00. Following the transaction, the director now directly owns 126,843 shares of the company’s stock, valued at $1,212,619.08. This trade represents a 19.13 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 72,256 shares of company stock valued at $674,739 over the last 90 days. Company insiders own 20.00% of the company’s stock.

Viemed Healthcare Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.